ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS)

Historical Holders from Q2 2018 to Q3 2025

Symbol
ATOS on Nasdaq
CUSIP
04962H506
Type / Class
Equity / Common Stock
Shares outstanding
129M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
19.4M
Holdings value
$16.8M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
63
Number of buys
20
Number of sells
-49
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 4.51% $4.84M 5.83M The Vanguard Group Jun 30, 2025
CVI Investments, Inc. 4.3% $4.53M 5.66M CVI Investments, Inc. Dec 31, 2024
BlackRock, Inc. 1.6% $1.72M 2.09M BlackRock, Inc. Jun 30, 2025

Institutional Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 19.4M $16.8M -$1.65M $0.87 63
2025 Q2 21.3M $17.7M -$5.65M $0.83 82
2025 Q1 28.4M $19.1M -$1.34M $0.67 82
2024 Q4 29.9M $28.3M +$2.34M $0.94 83
2024 Q3 27.3M $41.6M +$1.11M $1.52 85
2024 Q2 26.2M $31.2M +$6.14M $1.19 75
2024 Q1 19.2M $34.6M +$6.65M $1.80 64
2023 Q4 16M $14.1M -$97K $0.88 47
2023 Q3 16.2M $11.9M -$5.71K $0.74 51
2023 Q2 16M $20.1M -$385K $1.26 49
2023 Q1 16.4M $11.9M -$1.06M $0.72 43
2022 Q4 17.9M $9.49M -$744K $0.53 48
2022 Q3 19M $15.8M -$3.87M $0.83 43
2022 Q2 23.3M $25.4M -$11.4M $1.09 60
2022 Q1 33.8M $42.2M -$5.31M $1.25 72
2021 Q4 39.3M $63.3M +$10.8M $1.60 86
2021 Q3 31M $102M -$24.7M $3.26 89
2021 Q2 35.4M $224M +$173M $6.32 84
2021 Q1 10.8M $22.8M +$19.3M $2.11 51
2020 Q4 1.56M $1.48M +$454K $0.95 11
2020 Q3 721K $1.74M +$1.02M $2.42 21
2020 Q2 298K $1.13M +$254K $3.79 10
2020 Q1 226K $301K -$74K $1.35 6
2019 Q4 288K $451K +$55.9K $1.57 11
2019 Q3 249K $488K +$3K $1.96 10
2019 Q2 241K $614K -$188K $2.55 7
2019 Q1 290K $701K -$567K $3.49 8
2018 Q4 782K $798K +$220K $1.02 13
2018 Q3 566K $990K -$8.44K $1.74 7
2018 Q2 535K $1.18M +$1.18M $2.19 9